Detection of The TNFSF Members BAFF, APRIL, TWEAK and Their Receptors in Normal Kidney and Renal Cell Carcinomas

In advanced renal cell carcinoma (RCC), surgery combined with systemic chemotherapy and immunotherapy have had limited effectiveness. Therapeutic modalities targeting VEGF, PDGF, and c-kit using tyrosine kinase inhibitors and m-TOR using specific biologic factors are in development. Therapeutic appr...

Full description

Saved in:
Bibliographic Details
Main Authors: Vassiliki Pelekanou, George Notas, Katerina Theodoropoulou, Marilena Kampa, Dimitrios Takos, Vassilia-Ismini Alexaki, Jelena Radojicic, Frank Sofras, Andreas Tsapis, Efstathios N. Stathopoulos, Elias Castanas
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Analytical Cellular Pathology
Online Access:http://dx.doi.org/10.3233/ACP-2011-0001
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832567818729553920
author Vassiliki Pelekanou
George Notas
Katerina Theodoropoulou
Marilena Kampa
Dimitrios Takos
Vassilia-Ismini Alexaki
Jelena Radojicic
Frank Sofras
Andreas Tsapis
Efstathios N. Stathopoulos
Elias Castanas
author_facet Vassiliki Pelekanou
George Notas
Katerina Theodoropoulou
Marilena Kampa
Dimitrios Takos
Vassilia-Ismini Alexaki
Jelena Radojicic
Frank Sofras
Andreas Tsapis
Efstathios N. Stathopoulos
Elias Castanas
author_sort Vassiliki Pelekanou
collection DOAJ
description In advanced renal cell carcinoma (RCC), surgery combined with systemic chemotherapy and immunotherapy have had limited effectiveness. Therapeutic modalities targeting VEGF, PDGF, and c-kit using tyrosine kinase inhibitors and m-TOR using specific biologic factors are in development. Therapeutic approaches targeting TNF-alpha have shown limited efficacy, while anti-TRAIL (TNFSF10) antibodies have shown enhanced activity. The presence and potential significance of other members of the TNFSF has not been investigated. Here, we assayed the TNFSF members APRIL, BAFF, TWEAK and their receptors (BCMA, TACI, BAFFR, Fn14) in 86 conventional type clear cell RCC, using immunohistochemistry and correlated our findings with histological data and, in a limited series, follow-up of patients. We observed a differential expression of these TNFSF ligands and receptors in cancerous and non-cancerous structures. BAFF was found in all RCC; APRIL expression is associated with an aggressive phenotype, correlating negatively with patients' disease-free survival, while TWEAK and its receptor Fn14 are heterogeneously expressed, correlating negatively with the grade and survival of RCC patients. This is the first study, presenting together the TNFSF members APRIL, BAFF, TWEAK and their receptors in different areas of normal renal tissue and RCC, suggesting a potential role of these TNFSF members in renal tumor biology.
format Article
id doaj-art-a99575d246d04edd97d4b49f9155ddf3
institution Kabale University
issn 2210-7177
2210-7185
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series Analytical Cellular Pathology
spelling doaj-art-a99575d246d04edd97d4b49f9155ddf32025-02-03T01:00:34ZengWileyAnalytical Cellular Pathology2210-71772210-71852011-01-01341-2496010.3233/ACP-2011-0001Detection of The TNFSF Members BAFF, APRIL, TWEAK and Their Receptors in Normal Kidney and Renal Cell CarcinomasVassiliki Pelekanou0George Notas1Katerina Theodoropoulou2Marilena Kampa3Dimitrios Takos4Vassilia-Ismini Alexaki5Jelena Radojicic6Frank Sofras7Andreas Tsapis8Efstathios N. Stathopoulos9Elias Castanas10Laboratory of Experimental Endocrinology, School of Medicine, University of Crete, Heraklion, GreeceLaboratory of Experimental Endocrinology, School of Medicine, University of Crete, Heraklion, GreeceLaboratory of Experimental Endocrinology, School of Medicine, University of Crete, Heraklion, GreeceLaboratory of Experimental Endocrinology, School of Medicine, University of Crete, Heraklion, GreeceDepartment of Urology, School of Medicine, University of Crete, Heraklion, GreeceLaboratory of Experimental Endocrinology, School of Medicine, University of Crete, Heraklion, GreeceDepartment of Pathology, School of Medicine, University of Crete, Heraklion, GreeceDepartment of Urology, School of Medicine, University of Crete, Heraklion, GreeceInserm, U976, Paris, FranceDepartment of Pathology, School of Medicine, University of Crete, Heraklion, GreeceLaboratory of Experimental Endocrinology, School of Medicine, University of Crete, Heraklion, GreeceIn advanced renal cell carcinoma (RCC), surgery combined with systemic chemotherapy and immunotherapy have had limited effectiveness. Therapeutic modalities targeting VEGF, PDGF, and c-kit using tyrosine kinase inhibitors and m-TOR using specific biologic factors are in development. Therapeutic approaches targeting TNF-alpha have shown limited efficacy, while anti-TRAIL (TNFSF10) antibodies have shown enhanced activity. The presence and potential significance of other members of the TNFSF has not been investigated. Here, we assayed the TNFSF members APRIL, BAFF, TWEAK and their receptors (BCMA, TACI, BAFFR, Fn14) in 86 conventional type clear cell RCC, using immunohistochemistry and correlated our findings with histological data and, in a limited series, follow-up of patients. We observed a differential expression of these TNFSF ligands and receptors in cancerous and non-cancerous structures. BAFF was found in all RCC; APRIL expression is associated with an aggressive phenotype, correlating negatively with patients' disease-free survival, while TWEAK and its receptor Fn14 are heterogeneously expressed, correlating negatively with the grade and survival of RCC patients. This is the first study, presenting together the TNFSF members APRIL, BAFF, TWEAK and their receptors in different areas of normal renal tissue and RCC, suggesting a potential role of these TNFSF members in renal tumor biology.http://dx.doi.org/10.3233/ACP-2011-0001
spellingShingle Vassiliki Pelekanou
George Notas
Katerina Theodoropoulou
Marilena Kampa
Dimitrios Takos
Vassilia-Ismini Alexaki
Jelena Radojicic
Frank Sofras
Andreas Tsapis
Efstathios N. Stathopoulos
Elias Castanas
Detection of The TNFSF Members BAFF, APRIL, TWEAK and Their Receptors in Normal Kidney and Renal Cell Carcinomas
Analytical Cellular Pathology
title Detection of The TNFSF Members BAFF, APRIL, TWEAK and Their Receptors in Normal Kidney and Renal Cell Carcinomas
title_full Detection of The TNFSF Members BAFF, APRIL, TWEAK and Their Receptors in Normal Kidney and Renal Cell Carcinomas
title_fullStr Detection of The TNFSF Members BAFF, APRIL, TWEAK and Their Receptors in Normal Kidney and Renal Cell Carcinomas
title_full_unstemmed Detection of The TNFSF Members BAFF, APRIL, TWEAK and Their Receptors in Normal Kidney and Renal Cell Carcinomas
title_short Detection of The TNFSF Members BAFF, APRIL, TWEAK and Their Receptors in Normal Kidney and Renal Cell Carcinomas
title_sort detection of the tnfsf members baff april tweak and their receptors in normal kidney and renal cell carcinomas
url http://dx.doi.org/10.3233/ACP-2011-0001
work_keys_str_mv AT vassilikipelekanou detectionofthetnfsfmembersbaffapriltweakandtheirreceptorsinnormalkidneyandrenalcellcarcinomas
AT georgenotas detectionofthetnfsfmembersbaffapriltweakandtheirreceptorsinnormalkidneyandrenalcellcarcinomas
AT katerinatheodoropoulou detectionofthetnfsfmembersbaffapriltweakandtheirreceptorsinnormalkidneyandrenalcellcarcinomas
AT marilenakampa detectionofthetnfsfmembersbaffapriltweakandtheirreceptorsinnormalkidneyandrenalcellcarcinomas
AT dimitriostakos detectionofthetnfsfmembersbaffapriltweakandtheirreceptorsinnormalkidneyandrenalcellcarcinomas
AT vassiliaisminialexaki detectionofthetnfsfmembersbaffapriltweakandtheirreceptorsinnormalkidneyandrenalcellcarcinomas
AT jelenaradojicic detectionofthetnfsfmembersbaffapriltweakandtheirreceptorsinnormalkidneyandrenalcellcarcinomas
AT franksofras detectionofthetnfsfmembersbaffapriltweakandtheirreceptorsinnormalkidneyandrenalcellcarcinomas
AT andreastsapis detectionofthetnfsfmembersbaffapriltweakandtheirreceptorsinnormalkidneyandrenalcellcarcinomas
AT efstathiosnstathopoulos detectionofthetnfsfmembersbaffapriltweakandtheirreceptorsinnormalkidneyandrenalcellcarcinomas
AT eliascastanas detectionofthetnfsfmembersbaffapriltweakandtheirreceptorsinnormalkidneyandrenalcellcarcinomas